Atypical protein kinase C isoforms differentially regulate directional keratinocyte migration during wound healing.

Background: The epidermis possesses regenerative properties that become apparent only after wounding. Atypical protein kinase C (aPKC) isoforms aPKCζ and aPKCλ form a ternary complex with Par3 and Par6, and play crucial roles in establishing and maintaining epithelial cell polarity. The epidermal loss of aPKCλ results in progressive depletion of hair follicle stem cells.

Topical 3-bromopyruvate is a novel targeted therapy for melanoma in a preclinical model.

Background: Targeting cancer metabolism is a promising strategy in improving cancer treatment.

Objective: To introduce a targeted therapy with topical 3-bromopyruvate (3BP), aglycolytic inhibitor, into the clinic in the near future.

Method: We investigated the anti-tumor efficacy of 3BP on melanoma cells in vitro and in a preclinical model.

Rapid immunohistochemistry based on alternating current electric field for intraoperative diagnosis of brain tumors.

Rapid immunohistochemistry (R-IHC) can contribute to the intraoperative diagnosis of central nervous system (CNS) tumors. We have recently developed a new IHC method based on an alternating current electric field to facilitate the antigen-antibody reaction. To ensure the requirement of R-IHC for intraoperative diagnosis, 183 cases of CNS tumors were reviewed regarding the accuracy rate of diagnosis without R-IHC.

A novel immunohistochemical staining method allows ultrarapid detection of lymph node micrometastases while conserving antibody.

We developed a novel ultrarapid immunohistochemical staining method in which an AC electric field is used to facilitate detection of tumor cells. Frozen sections of non-small cell lung cancer in lymph nodes were fixed in acetone for 2 min, after which they were incubated for 2 min with an anti-pancytokeratin antibody cocktail and then with EnVision(TM) complex under an alternating current (AC) electric field. The sections were then incubated with a chromogen (3,3'diaminobenzidine) for 3 min and counterstained with hematoxylin.